FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033541583> ?p ?o ?g. }

• W3033541583 endingPage "314" @default.
• W3033541583 startingPage "307" @default.
• W3033541583 abstract "Treatment of massive pulmonary embolism (MPE) is controversial, with mortality rates ranging from 25% to 65%. Patients commonly present with profound shock or cardiac arrest. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly being used as a form of acute cardiopulmonary support in critically ill patients. We reviewed our institution's pulmonary embolism response team experience using VA-ECMO for patients presenting with advanced shock and/or cardiac arrest from MPE. From March 2017 to July 2019 we retrospectively reviewed 17 consecutive patients at our institution with MPE who were placed on VA-ECMO for initial hemodynamic stabilization. The mean patient age and body mass index was 55.8 years and 31.8, respectively. Ten of 17 patients (59%) required cardiopulmonary resuscitation before or during VA-ECMO cannulation. All patients had evidence of profound shock with a mean initial lactate of 8.95 mmol/L, a mean pH of 7.10, and a mean serum creatinine of 1.78 mg/dL. Seventeen of 17 cannulations (100%) were performed percutaneously, with 41% (n = 7) of patients placed on VA-ECMO while awake and using local analgesia. Five of 17 patients (29%) required reperfusion cannulas, with 0% incidence of limb loss. Overall survival was 13 of 17 patients (76%), with causes of death resulting from anoxic brain injury (n = 2), septic shock (n = 1), and cardiopulmonary resuscitation-induced hemorrhage from liver laceration (n = 1). In survivors, 12 of 13 patients (92%) were discharged without evidence of neurologic insult. The median duration of the VA-ECMO run for survivors was 86 hours (range, 45-218 hours). In survivors, the median length of time from ECMO cannulation to lactate clearance (<2.0 mmol/L) was 10 hours and the median length of time from ECMO cannulation to freedom from vasopressors was 6 hours. Three of 13 patients (23%) required concomitant percutaneous thrombectomy and catheter-directed thrombolysis to address persistent right heart dysfunction, with the remaining survivors (77%) receiving VA-ECMO and anticoagulation alone as definitive therapy for their MPE. The median intensive care and hospital length of stay for survivors was 9 and 13 days, respectively. VA-ECMO was effective at salvaging highly unstable patients with MPE. Survivors had rapid reversal of multiple organ failure with ECMO as their primary therapy. The majority of survivors required ECMO and anticoagulation alone for definitive therapy of their MPE." @default.
• W3033541583 created "2020-06-12" @default.
• W3033541583 creator A5010011251 @default.
• W3033541583 creator A5018710537 @default.
• W3033541583 creator A5029658565 @default.
• W3033541583 creator A5031375475 @default.
• W3033541583 creator A5035190993 @default.
• W3033541583 creator A5042838808 @default.
• W3033541583 creator A5053221361 @default.
• W3033541583 creator A5058490857 @default.
• W3033541583 creator A5069836420 @default.
• W3033541583 creator A5081922947 @default.
• W3033541583 date "2021-03-01" @default.
• W3033541583 modified "2023-09-30" @default.
• W3033541583 title "Venoarterial extracorporeal membrane oxygenation is an effective management strategy for massive pulmonary embolism patients" @default.
• W3033541583 cites W1919065085 @default.
• W3033541583 cites W1976273461 @default.
• W3033541583 cites W2018628685 @default.
• W3033541583 cites W2034936631 @default.
• W3033541583 cites W2038109753 @default.
• W3033541583 cites W2044868799 @default.
• W3033541583 cites W2069080267 @default.
• W3033541583 cites W2075776825 @default.
• W3033541583 cites W2085153891 @default.
• W3033541583 cites W2094155329 @default.
• W3033541583 cites W2107941853 @default.
• W3033541583 cites W2117686824 @default.
• W3033541583 cites W2136958487 @default.
• W3033541583 cites W2289173225 @default.
• W3033541583 cites W2569167292 @default.
• W3033541583 cites W2598170899 @default.
• W3033541583 cites W2767357672 @default.
• W3033541583 cites W2769737736 @default.
• W3033541583 cites W2772496259 @default.
• W3033541583 cites W2790720346 @default.
• W3033541583 cites W2884752217 @default.
• W3033541583 cites W2917969924 @default.
• W3033541583 cites W2972803715 @default.
• W3033541583 cites W2985018965 @default.
• W3033541583 cites W2999947242 @default.
• W3033541583 doi "https://doi.org/10.1016/j.jvsv.2020.04.033" @default.
• W3033541583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32505687" @default.
• W3033541583 hasPublicationYear "2021" @default.
• W3033541583 type Work @default.
• W3033541583 sameAs 3033541583 @default.
• W3033541583 citedByCount "18" @default.
• W3033541583 countsByYear W30335415832020 @default.
• W3033541583 countsByYear W30335415832021 @default.
• W3033541583 countsByYear W30335415832022 @default.
• W3033541583 countsByYear W30335415832023 @default.
• W3033541583 crossrefType "journal-article" @default.
• W3033541583 hasAuthorship W3033541583A5010011251 @default.
• W3033541583 hasAuthorship W3033541583A5018710537 @default.
• W3033541583 hasAuthorship W3033541583A5029658565 @default.
• W3033541583 hasAuthorship W3033541583A5031375475 @default.
• W3033541583 hasAuthorship W3033541583A5035190993 @default.
• W3033541583 hasAuthorship W3033541583A5042838808 @default.
• W3033541583 hasAuthorship W3033541583A5053221361 @default.
• W3033541583 hasAuthorship W3033541583A5058490857 @default.
• W3033541583 hasAuthorship W3033541583A5069836420 @default.
• W3033541583 hasAuthorship W3033541583A5081922947 @default.
• W3033541583 hasConcept C126322002 @default.
• W3033541583 hasConcept C139940330 @default.
• W3033541583 hasConcept C141071460 @default.
• W3033541583 hasConcept C178853913 @default.
• W3033541583 hasConcept C2776265017 @default.
• W3033541583 hasConcept C2776858399 @default.
• W3033541583 hasConcept C2777055891 @default.
• W3033541583 hasConcept C2777628635 @default.
• W3033541583 hasConcept C2778165595 @default.
• W3033541583 hasConcept C2778384902 @default.
• W3033541583 hasConcept C2781300812 @default.
• W3033541583 hasConcept C31861589 @default.
• W3033541583 hasConcept C42219234 @default.
• W3033541583 hasConcept C71924100 @default.
• W3033541583 hasConceptScore W3033541583C126322002 @default.
• W3033541583 hasConceptScore W3033541583C139940330 @default.
• W3033541583 hasConceptScore W3033541583C141071460 @default.
• W3033541583 hasConceptScore W3033541583C178853913 @default.
• W3033541583 hasConceptScore W3033541583C2776265017 @default.
• W3033541583 hasConceptScore W3033541583C2776858399 @default.
• W3033541583 hasConceptScore W3033541583C2777055891 @default.
• W3033541583 hasConceptScore W3033541583C2777628635 @default.
• W3033541583 hasConceptScore W3033541583C2778165595 @default.
• W3033541583 hasConceptScore W3033541583C2778384902 @default.
• W3033541583 hasConceptScore W3033541583C2781300812 @default.
• W3033541583 hasConceptScore W3033541583C31861589 @default.
• W3033541583 hasConceptScore W3033541583C42219234 @default.
• W3033541583 hasConceptScore W3033541583C71924100 @default.
• W3033541583 hasIssue "2" @default.
• W3033541583 hasLocation W30335415831 @default.
• W3033541583 hasOpenAccess W3033541583 @default.
• W3033541583 hasPrimaryLocation W30335415831 @default.
• W3033541583 hasRelatedWork W2028209775 @default.
• W3033541583 hasRelatedWork W2074088163 @default.
• W3033541583 hasRelatedWork W2184287961 @default.
• W3033541583 hasRelatedWork W2349687057 @default.
• W3033541583 hasRelatedWork W2375342862 @default.

• next